OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Interleukin-2
- Indications Cancer
- Focus Therapeutic Use
- 12 May 2011 Biomarkers information updated
- 16 Nov 2008 Last checked against ClinicalTrials.gov.
- 10 Sep 2005 New trial record.